FGF18 Enhances Migration and the Epithelial-Mesenchymal Transition in Breast Cancer by Regulating Akt/GSK3β/Β-Catenin Signaling
暂无分享,去创建一个
Jinghang Zhang | Xianwei Wang | Zhiwei Feng | Yanlong Liu | Jiateng Zhong | Jian Yu | Na Song | W. Su | Haijun Wang | Jinbo Qi | Bo Yang | Xiaoyan Ma | Tengteng Gu | Qing Hu | Qiuyue Chen
[1] Zhidong Lv,et al. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2 , 2017, Cellular Physiology and Biochemistry.
[2] Jinshan Zhang,et al. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma , 2017, Cellular Physiology and Biochemistry.
[3] Hui-Li Qu,et al. Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition , 2017, Cellular Physiology and Biochemistry.
[4] F. Meng,et al. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro , 2017, Cellular Physiology and Biochemistry.
[5] G. Hortobagyi,et al. Current challenges of metastatic breast cancer , 2016, Cancer and Metastasis Reviews.
[6] Ping Yang,et al. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression , 2016, Oncotarget.
[7] L. V. van't Veer,et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. , 2016, The New England journal of medicine.
[8] Jordan Anaya,et al. OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs , 2016, PeerJ Comput. Sci..
[9] H. Ouyang,et al. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia* , 2015, The Journal of Biological Chemistry.
[10] C. Criscitiello,et al. Targeting fibroblast growth factor receptor pathway in breast cancer , 2015, Current opinion in oncology.
[11] M. Lai,et al. GDF15 promotes EMT and metastasis in colorectal cancer , 2015, Oncotarget.
[12] B. Tang,et al. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer , 2015, Oncotarget.
[13] L. Pusztai,et al. A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients , 2015, Genome Medicine.
[14] Sydney L. Stoops,et al. Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition , 2015, Oncotarget.
[15] H. Ouyang,et al. Protein Phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros‐mediated repression of TdT in thymocytes and T‐cell leukemia , 2014, Pediatric blood & cancer.
[16] I. Hedenfalk,et al. Molecular Subtyping of Serous Ovarian Tumors Reveals Multiple Connections to Intrinsic Breast Cancer Subtypes , 2014, PloS one.
[17] E. Oliva,et al. FGF18 as a prognostic and therapeutic biomarker in ovarian cancer. , 2013, The Journal of clinical investigation.
[18] M. Sormani,et al. Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer , 2013, International journal of molecular sciences.
[19] C. Delacourt,et al. Profiling target genes of FGF18 in the postnatal mouse lung: possible relevance for alveolar development. , 2011, Physiological genomics.
[20] T. Mohr,et al. Up‐regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis , 2011, Hepatology.
[21] M. J. van de Vijver,et al. The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] S. Spiegl-Kreinecker,et al. Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration , 2010, British Journal of Cancer.
[23] S. Paik,et al. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays. , 2009, Breast.
[24] Ahmed H. Tewfik,et al. Early detection of ovarian cancer using group biomarkers , 2008, Molecular Cancer Therapeutics.
[25] W. Berger,et al. FGF18 in colorectal tumour cells: autocrine and paracrine effects. , 2007, Carcinogenesis.
[26] D. Ornitz,et al. FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. , 2007, Developmental biology.
[27] A. Gressner,et al. Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation. , 2006, Biochemical and biophysical research communications.
[28] A. Guntur,et al. Glycogen synthase kinase 3 controls endochondral bone development: contribution of fibroblast growth factor 18. , 2005, Developmental biology.
[29] M. Buschmann,et al. Fibroblast Growth Factor (FGF) 18 Signals through FGF Receptor 3 to Promote Chondrogenesis* , 2005, Journal of Biological Chemistry.
[30] Yusuke Nakamura,et al. Disruption of Fibroblast Growth Factor Signal Pathway Inhibits the Growth of Synovial Sarcomas: Potential Application of Signal Inhibitors to Molecular Target Therapy , 2005, Clinical Cancer Research.
[31] M. Cronin,et al. Gene expression markers for breast cancer prognosis of , 2004 .
[32] Yusuke Nakamura,et al. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. , 2003, Cancer research.
[33] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[34] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. Bicknell,et al. Hypoxia and oxidative stress in breast cancer: Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer , 2001, Breast Cancer Research.
[36] F. McCormick,et al. Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling* , 2000, The Journal of Biological Chemistry.
[37] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[38] Randall T Moon,et al. Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways , 1999, Oncogene.
[39] Michael Kühl,et al. Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.
[40] S. Hellman. Dogma and inquisition in medicine. Breast cancer as a case study , 1993, Cancer.
[41] S. Noguchi,et al. Multi-gene classifiers for prediction of recurrence in breast cancer patients , 2015, Breast Cancer.
[42] T. Haque,et al. A review of FGF18: Its expression, signaling pathways and possible functions during embryogenesis and post-natal development. , 2007, Histology and histopathology.
[43] Josef Gotzmann,et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. , 2004, Mutation research.
[44] T. Barrette,et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.